Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantp = 1.69E−040.0× alphagold
The results from the linear regression model, adjusted for age and sex covariates, yielded several nominally significant variants in the PTPN2 region including the top finding of rs78943928 ( p = 1.69E−04) which resides approximately 29 and 22 kbp 3′ of PTPN2 isoform 1 and isoform 2, respectively.
nominally significantP value < 1.9 × 10 −40.0× alphagold
Reassuringly, the association with a clinical diagnosis of “vitamin D deficiency” (ICD-10 E55; N cases = 3150, N noncases = 344,619) was negative and nominally significant (i.e., higher DBP associated with a reduced risk of a clinical diagnosis of vitamin D deficiency; beta = −0.07, standard error = 0.02, P value < 1.9 × 10 −4 ).
nominally significantp-value = 0.00020.0× alphagold
Nevertheless, congruent with literature indicating central channels being the most affected in SCZ during auditory processing, all ERP metrics displayed nominally significant group differences at Cz: P50 ratio – e.s. = 0.92 SD, uncorrected p-value = 0.0002, MMN amplitude – e.s. = −0.49 SD, p-value = 0.008, ASSR power – e.s. = –0.56 SD, p-value = 0.008, and ASSR phase synchrony – e.s. = –0.62 SD, p-value = 0.002.
nominally significantp=0.00030.0× alphagold
A second analysis considering fatty acid composition of nominally significant triacylglycerols, revealed enrichment of triacylglycerols containing C20:4, C18:2 and C16:0 in the PCOS group (p=0.0003, <0.00001 and 0.03, respectively) (also highlighted in Figure 2B ).
nominally significantp = 3 × 10 −40.0× alphagold
Two traits showed nominally significant genetic correlation in both phenotypes but in opposite directions including intelligence (BioVU: rg = −0.53, p = 3 × 10 −4 , UK Biobank: rg = 0.19, p = 0.044) and years of schooling [ 38 ] (BioVU: rg = −0.53, p = 3.3 × 10 −5 , UK Biobank: rg = 0.19, p = 0.007).
nominally significantp = 0.00030.0× alphagold
Additionally, we identified one variant (rs2588469) that showed genome-wide significant pleiotropic effects (PLEIO p = 1.18 × 10 −8 ), but showed only nominally significant associations with the three disorders investigated (BP: beta = −0.056, p = 0.0003; MDD: OR = 0.98, p = 9.9 × 10 −5 ; SCZ OR = 1.062, p = 0.0008).
nominally significantp = 0.00040.0× alphagold
However, several lines of evidence point to an effect of the lower dose on exercise endurance: (i) tiotropium/olodaterol 2.5/5 μg significantly improved EET during CWRCE compared with placebo in both MORACTO ® studies [26.5% ( p < 0.0001) and 12.1% ( p = 0.0003)]; (ii) there was a nominally significant improvement in EET during CWRCE after 6 weeks (22.1%, nominal p = 0.0004) in the present study; (iii) in post hoc analysis, change from baseline in EET during CWRCE after 6 and 12 weeks was nominally significant.
nominally significantP = 0.00040.0× alphagold
Compared to controls, a significant or nominally significant decrease in cerebellar TDP-43 was seen in FTLD-TDP cases in unadjusted analysis (β: − 0.4087, 95% CI: − 0.6325 to − 0.1849, P = 0.0004, Fig. 1 B, Table 2 ) and analysis adjusted for age and sex (β: − 0.2701, 95% CI: − 0.4850 to − 0.05514, P = 0.0142, Table 2 ), respectively.
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.
Acta Neuropathol Commun · 2022 · PMC9310392
nominally significantp = 4.1 × 10 −40.0× alphagold
Phenome-wide association (PheWAS) of n = 10,168 phenotypes revealed nominally significant association of p.Arg1231Cys with ischemic stroke (OR [95%CI] = 4.0 [1.9, 8.6]), p = 4.1 × 10 −4 ), all strokes combined (OR [95% CI] = 1.9 [1.1, 3.5], p = 0.031), hypertension (ICD 10 code I10) (OR [95% CI] = 1.5 [1.1, 2.2], p = 0.019), and recurrent major depression (OR [95% CI] = 3.2 [1.5, 6.8], p = 0.0031) (Supplementary Data 2 ).
nominally significantp = 4.3 × 10 −40.0× alphagold
We observed nominally significant association signals in several genes of a priori interest, including BRCA2 (p = 4.3 × 10 −4 ), STK11 (p = 0.003), PALB2 (p = 0.019), and TP53 (p = 0.037), and reported risk estimates for known pathogenic variants and variants of uncertain significance (VUS) in these genes.